Hybridex Biosciences aims to enable the next generation of precision gene editing therapeutics through novel antisense technology. Our platform technology seeks to improve safety, control, and versatility of both ex vivo and in vivo gene editing therapeutics.
Company Details
- Employees
- 2
- Founded
- 2022
- Address
- New Haven , Connecticut 06510, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://Hybridexbio.com
- Keywords
- Gene Editing.
- HQ
- New Haven , Connecticut
Hybridex Biosciences Questions
Hybridex Biosciences's website is http://Hybridexbio.com
Hybridex Biosciences's LinkedIn profile is https://www.linkedin.com/company/hybridex-biosciences
Hybridex Biosciences has
2 employees.
View email and phone details for 2
employees at Hybridex Biosciences.
Hybridex Biosciences's industry is
Biotechnology Research
Hybridex Biosciences's top competitors are
Epitet Therapeutics,
Biohaven,
Tangen Bioscience,
Erythrocure,
B&b Vicus,
Sidero Bioscience,
The Barthwell Group,
Inovera Bioscience Inc,
Verinomics,
John Riordan, Leadership And Organization Development.
Hybridex Biosciences's categories are Biotechnology Research
Hybridex Biosciences's founding year is 2022
